Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
HOOKIPA Pharma Inc. - Common Stock
(NQ:
HOOK
)
0.8403
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Aug 7, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about HOOKIPA Pharma Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
HOOKIPA Pharma Announces Completion of Sale of HBV and HIV Assets to Gilead
October 31, 2025
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
HOOKIPA Pharma Announces Intention to Voluntarily Delist and Deregister its Common Stock
July 18, 2025
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
May 22, 2025
Via
Benzinga
Why HOOKIPA Pharma (HOOK) Stock Is Volatile Today
↗
July 08, 2024
HOOKIPA Pharma shares are trading lower by 10.9% during Monday's session. The company announced a 1-for-10 reverse stock split.
Via
Benzinga
Deep Dive Into HOOKIPA Pharma Stock: Analyst Perspectives (4 Ratings)
↗
May 21, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
May 01, 2025
Via
Benzinga
HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment of HIV
January 30, 2025
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
HOOKIPA Pharma Announces Notice to Shareholders Regarding U.K. Disclosure Requirements
January 07, 2025
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
Deal Dispatch: Vera Bradley Is A Mixed Bag, Modell's Ex-CEO Explores Party City
↗
January 03, 2025
Vera Bradley faces shareholder pressure for underperformance, while acquisitions and restructurings define this week's deal landscape.
Via
Benzinga
HOOKIPA Pharma Reports Third Quarter 2024 Financial Results and Provides Recent Business Updates
November 14, 2024
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
HOOKIPA Pharma’s Eseba-vec Highlighted in SITC Late-Breaker
November 11, 2024
Phase 2 trial evaluating eseba-vec/pembrolizumab combination resulted in a 52% ORR in PD-L1 CPS>20 patients and encouraging PFS and OS data, supported by highly durable and tumor-specific T cell...
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
HOOKIPA Pharma to Present Eseba-vec Combo in Frontline HNSCC as a Late-Breaker Poster Presentation at SITC 2024
October 31, 2024
Society of Immunotherapy of Cancer (SITC) poster to be presented by collaborator from Memorial Sloan Kettering Cancer Center, Dr. Alan Ho, on November 9, 2024
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
October 30, 2024
Via
Benzinga
HOOKIPA Pharma Doses First Patients with Eseba-vec as Adjuvant Therapy in Phase 2 Investigator Lead Trial for Head & Neck Cancer
October 30, 2024
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
HOOKIPA Pharma to Present Strong Preclinical HB-700 Dataset
September 24, 2024
Preclinical proof-of-concept package to be presented at Industry Summit on RAS being held September 24-26, 2024
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
Kaskela Law LLC Announces Shareholder Investigation of HOOKIPA Pharma Inc. (NASDAQ: HOOK) and Encourages Investors to Contact the Firm
September 17, 2024
From
Kaskela Law LLC
Via
Business Wire
HOOKIPA Pharma Announces Board of Directors Changes
August 30, 2024
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
HOOK Stock Earnings: HOOKIPA Pharma Misses EPS, Misses Revenue for Q2 2024
↗
August 09, 2024
HOOK stock results show that HOOKIPA Pharma missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via
InvestorPlace
HOOKIPA Pharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights
August 08, 2024
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
HOOKIPA Pharma Announces Leadership Changes to Intensify Focus on HB-200
July 22, 2024
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
HOOKIPA Pharma Announces Effective Date of 1-for-10 Reverse Stock Split
July 08, 2024
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
HOOKIPA Pharma Announces First Person Dosed in Phase 1b Clinical Trial of HB-500 for the Treatment of HIV
July 01, 2024
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
Keurig Dr Pepper To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
↗
June 05, 2024
Via
Benzinga
HOOKIPA Pharma Announces Updated Phase 2 Clinical Data at the American Society of Clinical Oncology 2024 Annual Meeting
June 04, 2024
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
HOOKIPA Pharma to Host Investor Call on HB-200 Data Presented at American Society of Clinical Oncology 2024 Annual Meeting
May 30, 2024
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
↗
May 27, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
May 24, 2024
Via
Benzinga
HOOKIPA Pharma Announces Positive Clinical Data to be Presented at the American Society for Clinical Oncology 2024 Annual Meeting
May 23, 2024
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
Penny Stock Sleepers: 7 Under-the-Radar Gems Ready to Launch
↗
May 16, 2024
Penny stocks to buy understandably offers many enticing attributes, not least of which is the potential for tremendous returns.
Via
InvestorPlace
HOOK Stock Earnings: HOOKIPA Pharma Beats EPS, Beats Revenue for Q1 2024
↗
May 09, 2024
HOOK stock results show that HOOKIPA Pharma beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
